joimax® Shows Strong Growth Trend Again in 2016 and is Issued New Patents, the Company Now Holds More Than 150 Patents and Trademarks Worldwide

January 16, 2017

IRVINE, Calif.–(BUSINESS WIRE)–Today, German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, joimax®, announced growing sales figures. Record sales in 2016 are representing another 31% growth vs. 2015. This is in line with a Compound Annual Growth Rate (CAGR) from 2007 – 2016 of around 32%. Projections into 2017 show accelerated growth due to the worldwide increasing adoption rate of joimax® procedures.

joimax® is active in 45 countries and enjoys a strong reputation in Europe and Asia and is now serving the U.S. market as well. “The entry in force of the CPT 2017 reimbursement Codebook (Current Procedural Terminology) as of January 1 2017 is a milestone towards the full acceptance of endoscopic minimally invasive spine surgery techniques. The codebook now contains the first endoscopic spinal surgery code, under which the specific transforaminal (TESSYS®) and/or interlaminar (iLESSYS®) procedures marketed by joimax® are now eligible in the U.S. This will further contribute to fully increase sales in the U.S. as well,” states Wolfgang Ries, Founder and CEO of joimax®.

joimax® technologies are based on worldwide intellectual property and the company holds now more than 150 patents and trademarks. In 2016 18 patents and patent publications were issued to joimax®. The latest one is Patent No. EP 2 983 622 for the EndoLIF® Cage, which has been introduced to offer a minimally invasive, as well as open (TLIF) alternative for fusion in the lumbar spine, as an optimal treatment option for surgeons.

The company is busy inventing and innovating its next minimally invasive systems that will include newer implants based on the EndoLIF® technology as well as decompression methods based on its endoscopic systems. This will be completed with Intracs®, the new Interaoperative Navigation Tracking & Control System, which joimax® instruments can be navigated directly at the tip. The Intracs ®Navigation and Monitor Unit is integrated in the joimax® Endoscopic Tower and all necessary tools are tailored for the TESSYS®(transforaminal) and iLESSYS® (interlaminar) procedures as well as for minimally invasive stabilization procedures, like EndoLIF®(Lumbar Interbody Fusion) and Percusys® (Percutaneous Screw-Rod Stabilization).

About joimax®

Founded in Karlsruhe, Germany, in 2001, joimax® is the leading developer and marketer of complete systems for endoscopic minimally invasive spinal surgery. With TESSYS® (transforaminal), iLESSYS® (interlaminar) and CESSYS® (cervical) for decompression procedures, MultiZYTE® RT (e.g. for rhizotomy) and with MultiZYTE® SI for SI-Joint therapy or with EndoLIF® and Percusys® for endoscopic minimally invasive assisted stabilizations, proven endoscopic systems are provided that, together, cover a whole variety of indications. With the newly launched Intracs® system, navigation is now faster, safer and more accurate than ever before using an electromagnetic (EM) field.

In procedures for herniated disc, stenosis, pain therapy or spinal stabilization treatment, surgeons utilize joimax® technologies to operate through small incisions – under local or full anesthetic – via tissue and muscle-sparing corridors through natural openings into the spinal canal (e.g. intervertebral foramen, the “Kambin triangle”).


joimax® Inc.
Melissa Brumley
001 949 859 3472

Related Articles

Back to top button